Waning Humoral Immune Response to SARS-CoV-2 Vaccination with Symptomatic Infection after Initiation of Anti-CD20 Treatment in a Patient with Multiple Sclerosis

Hoepner, Robert; Salmen, Anke (2022). Waning Humoral Immune Response to SARS-CoV-2 Vaccination with Symptomatic Infection after Initiation of Anti-CD20 Treatment in a Patient with Multiple Sclerosis. Clinical and translational neuroscience, 6(1), p. 8. MDPI 10.3390/ctn6010008

[img]
Preview
Text
Hoepner__Salmen__2022__Warning_Humoral_Immune_Response.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (183kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Hoepner, Robert, Salmen, Anke

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2514-183X

Publisher:

MDPI

Language:

English

Submitter:

Chantal Kottler

Date Deposited:

03 Nov 2022 11:57

Last Modified:

05 Dec 2022 16:27

Publisher DOI:

10.3390/ctn6010008

BORIS DOI:

10.48350/174462

URI:

https://boris.unibe.ch/id/eprint/174462

Actions (login required)

Edit item Edit item
Provide Feedback